非洛地平联合倍他洛克治疗34例高血压临床效果分析  

Analysis of felodipine combined with betaloc in the treatment of 34 cases of hypertension

作　　者：周波[1] 刘红臻[1] 王清[1] 

机构地区：[1]山东省青岛市第八人民医院,266100

出　　处：《中国实用医药》2014年第22期8-10,共3页China Practical Medicine

摘　　要：目的探究与分析非洛地平联合倍他洛克治疗34例高血压临床效果分析。方法高血压患者34例,将其作为临床研究对象,对其采用非洛地平联合倍他洛克治疗,观察该组患者治疗前后血压及生理指标变化情况。结果该组患者在治疗1周后较治疗前相比,收缩压及舒张压有了明显下降,治疗6～12周血压下降更加显著(P<0.05);该组患者治疗前后血清总胆固醇(TC)、甘油三酯(TG)、血尿素氮(BUN)、血肌酐(CR)指标差异无统计学意义(P>0.05);该组患者治疗后较治疗前相比,血尿酸(UA)和白蛋白(Alb)有了明显下降(P<0.05)。该组患者共34例中出现3例面红(8.82%)、4例心悸(11.76%)、3例头痛(8.82%)、3例头晕(8.82%),因症状较轻,未采取停药处理,数天后症状自行消失。结论对于高血压患者采用非洛地平联合倍他洛克治疗后的临床效果较为显著,能够有效降低患者血压,且在治疗过程中未出现不良反应,具有一定的安全性。Objective To explore and analyze the combination of felodipine and metoprolol on the clinical effect of treatment of 34 cases of hypertension. Methods Selected 34 cases of hypertensive patients as the research object, treated with combination of felodipine and metoprolol treatment, observed the change of blood pressure and physiological index before and after the treatment. Results Systolic and diastolic blood pressure decreased obviously, after 6~12 weeks, the blood pressure decreased significantly（P〈0.05）;TC, TG, BUN, CR showed no significant difference before and after treatment（P〉0.05）;UA and Alb in urine was decreased obviously after treatment（P〈0.05）. The group of 3 patients with a total of 34 cases of red appeared （8.82%）, 4 cases（11.76%） of palpitation, 3 cases（8.82%） of headache, 3 cases（8.82%） of dizziness, because the symptom was lighter, without taking the withdrawal treatment, several days later the symptoms disappeared. Conclusion Clinical effect of combination of felodipine and metoprolol in treatment of hypertensive patients is significant, which can effectively reduce the blood pressure safely with no adverse reaction in the treatment process.

关 键 词：非洛地平 倍他洛克 高血压 

分 类 号：R544.1[医药卫生—心血管疾病]